1. Home
  2. RDY vs HTH Comparison

RDY vs HTH Comparison

Compare RDY & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • HTH
  • Stock Information
  • Founded
  • RDY 1984
  • HTH 1998
  • Country
  • RDY India
  • HTH United States
  • Employees
  • RDY N/A
  • HTH N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • RDY Health Care
  • HTH Finance
  • Exchange
  • RDY Nasdaq
  • HTH Nasdaq
  • Market Cap
  • RDY 2.1B
  • HTH 2.0B
  • IPO Year
  • RDY N/A
  • HTH 2004
  • Fundamental
  • Price
  • RDY $13.94
  • HTH $29.07
  • Analyst Decision
  • RDY Buy
  • HTH Hold
  • Analyst Count
  • RDY 1
  • HTH 2
  • Target Price
  • RDY $17.00
  • HTH $34.00
  • AVG Volume (30 Days)
  • RDY 2.9M
  • HTH 414.4K
  • Earning Date
  • RDY 05-06-2025
  • HTH 04-24-2025
  • Dividend Yield
  • RDY 3.50%
  • HTH 2.49%
  • EPS Growth
  • RDY 2.68
  • HTH 3.22
  • EPS
  • RDY 0.75
  • HTH 1.74
  • Revenue
  • RDY $3,637,607,642.00
  • HTH $1,187,813,000.00
  • Revenue This Year
  • RDY $17.23
  • HTH N/A
  • Revenue Next Year
  • RDY $9.19
  • HTH $3.18
  • P/E Ratio
  • RDY $18.46
  • HTH $16.64
  • Revenue Growth
  • RDY 14.74
  • HTH 0.88
  • 52 Week Low
  • RDY $12.26
  • HTH $26.67
  • 52 Week High
  • RDY $16.89
  • HTH $35.32
  • Technical
  • Relative Strength Index (RSI)
  • RDY 62.08
  • HTH 45.00
  • Support Level
  • RDY $13.59
  • HTH $28.35
  • Resistance Level
  • RDY $13.04
  • HTH $28.91
  • Average True Range (ATR)
  • RDY 0.36
  • HTH 1.14
  • MACD
  • RDY 0.11
  • HTH 0.05
  • Stochastic Oscillator
  • RDY 97.78
  • HTH 56.93

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: